• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Ebola virus - Articles and news items

ebola

PREVAIL IV – a trial to investigate if GS-5734 eliminates Ebola virus from semen

Industry news / 5 July 2016 / Victoria White, Digital Content Producer

The six-month study will enrol 60 to 120 Ebola survivors whose semen has evidence of Ebola virus RNA prior to their enrolment…

ebola-vaccine

Positive Phase I results for preventive Ebola vaccine regimen

Industry news / 20 April 2016 / Victoria White, Digital Content Producer

Data from a Phase I study of a preventive Ebola vaccine regimen suggest that the regimen was well-tolerated by healthy volunteers and immunogenic…

ebola vaccine

Inovio’s Ebola vaccine generates robust immune responses in humans

Industry news / 30 March 2016 / Victoria White

Inovio’s Ebola vaccine, INO-4212, was safe, tolerable, and generated strong T cell and antibody responses in its Phase I study of 75 healthy subjects…

GS-5734

Gilead’s GS-5734 given to UK Ebola patient

Industry news / 22 October 2015 / Victoria White

GS-5734 was discovered as part of Gilead’s programme to screen compounds in its libraries for activity against a range of potential emerging viruses, including Ebola…

ebola

BARDA funding awarded to accelerate Ebola vaccine programme

Industry news / 15 September 2015 / Victoria White

Crucell Holland has been awarded $28.5 million from BARDA to help accelerate the development of its investigational Ebola prime-boost vaccine regimen…

ebola

Sierra Leone down to last chain of Ebola transmission

Industry news / 17 August 2015 / Victoria White

An epidemiological week has now passed with no new Ebola cases in Sierra Leone for the first time since the beginning of the outbreak…

eib-ebola

Ebola vaccine found to have 100% efficacy in a Phase 3 trial

Industry news / 31 July 2015 / Victoria White

Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial…

ebola-novavax

Novavax announces positive top-line data from Phase 1 Ebola vaccine trial

Industry news / 22 July 2015 / Victoria White

Novavax has announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein recombinant nanoparticle vaccine candidate…

tekmira

Tekmira to change company name; suspends development of ebola drug

Industry news / 21 July 2015 / Victoria White

Tekmira Pharmaceuticals Corporation has announced plans to change its corporate name to Arbutus Biopharma Corporation, to be effective by 3 August 2015…

ebola-MVA-BN-Filo

Oxford Vaccine Group initiates Phase 2 study of Ebola prime-boost vaccine regimen combining MVA-BN-Filo and Ad26.ZEBOV

Industry news / 15 July 2015 / Victoria White

Oxford Vaccine Group has initiated a Phase 2 clinical study of the Ebola prime-boost vaccine regimen that combines MVA-BN-Filo with Ad26.ZEBOV…

TKM-Ebola-Guinea

Enrolment stops for Phase II TKM-Ebola-Guinea trial

Industry news / 23 June 2015 / Victoria White

Tekmira has announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.

eib-ebola

EIB supports Bavarian Nordic’s development of Ebola and cancer vaccines

Industry news / 13 May 2015 / Victoria White

EIB has reaffirmed its commitment to respond to the Ebola pandemic by providing a EUR 50m loan to Bavarian Nordic for accelerated development of a vaccine…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +